Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Investors
Investor FAQs
- 1. Where are Newron shares traded?
- 2. What is Newron’s ticker symbol?
- 3. What is Newron’s number of outstanding shares?
- 4. What is the date of your next Annual General Meeting?
- 5. Are there any limitations on voting rights for registered shareholders?
- 6. When does Newron’s fiscal year end?
- 7. What accounting convention does Newron adhere to?
- 8. How can I get a copy of your Annual Report?
- 9. Can I subscribe to receive your news automatically?
6. When does Newron’s fiscal year end?
Newron’s fiscal year is the 12-months ending December 31.
8. How can I get a copy of your Annual Report?
Our Annual Report is now available on this website.
You can also order a printed copy by sending an e-mail to: ir@newron.com
9. Can I subscribe to receive your news automatically?
We have a subscription form online in which you can register for news. Each time something new is published on our Investor Relations website you will receive an E-mail alert. Click here to Register for updates